Latest News

  • Alkermes to Host Conference Call to Discuss First Quarter 2019 Financial Results Read More
  • Alkermes Announces Positive Topline Results From Innovative Study of ARISTADA® and INVEGA SUSTENNA® for the Treatment of Schizophrenia Read More
  • Alkermes Announces Departure of Jim Robinson Read More

Investors

Working at Alkermes